戻る Agenda
Session 2: 21st Century Cures and PDUFA: Combination Products Implications
Session Chair(s)
Carla Cartwright, JD, LLM
Director, Federal Affairs
Johnson & Johnson, United States
Learning Objective :
Speaker(s)
21st Century Cures from Three Sides: Hill, Agency, and Industry Perspectives
Kalah Auchincloss
Greenleaf Health, Inc., United States
Senior Vice President, Regulatory Compliance
Speaker
Cartier Esham, PhD, MSc
Biotechnology Innovation Organization (BIO), United States
Chief Scientific Officer
Speaker
Grace Stuntz
Senate HELP Committee, Republican Staff, United States
FDA Policy Advisor
Speaker
Remy Brim
FDA, United States